A study found that new monoclonal antibody drugs for Alzheimer's may slow cognitive impairment through boosting levels of a specific protein in the brain. A study published in the journal Brain shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback